TriReme Medical Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 106
Employees
  • Latest Deal Type
  • Merger of Eq.

TriReme Medical General Information

Description

Developer, manufacturer and distributor of advanced therapeutic technology systems designed for the treatment of complex vascular disease. The company develops next generation percutaneous devices for the treatment of coronary and peripheral vascular disease. Its novel balloon and stent therapies are specifically designed for the large, unmet clinical needs in the complex coronary and peripheral artery disease markets, providing physicians with new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Acquirer
Primary Office
  • 7060 Koll Center Parkway
  • Suite 300
  • Pleasanton, CA 94566
  • United States
+1 (925) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TriReme Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger of Equals 11-Jul-2013 000.00 Completed Generating Revenue
6. Later Stage VC 28-Nov-2012 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series D) 12-Oct-2010 0000 000.00 000.00 Completed Startup
4. Early Stage VC 10-Nov-2009 00.000 000.00 Completed Startup
3. Early Stage VC 16-Oct-2007 000.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 27-Apr-2006 $3.44M $5.36M 000.00 Completed Startup
1. Early Stage VC (Series A) 11-Nov-2005 $1.92M $1.92M 000.00 Completed Startup
To view TriReme Medical’s complete valuation and funding history, request access »

TriReme Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 2,264,157 $0.001000 $0.12 $1.52 $1.52 1x $1.52 3.2%
Series A 2,271,276 $0.001000 $0.08 $1 $1 1x $1 3.21%
To view TriReme Medical’s complete cap table history, request access »

TriReme Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer, manufacturer and distributor of advanced therapeutic technology systems designed for the treatment of complex
Surgical Devices
Pleasanton, CA
106 As of 2016
000.00
00000000000 000.00

000000 (

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea com
00000000 0000000
Durham, NC
00 As of 0000
000.00
00000000000 000.00

0000

lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
00000000 0000000
Bothell, WA
00 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TriReme Medical Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tryton (Surgical Devices) Venture Capital-Backed Durham, NC 00 000.00 00000000000 000.00
0000 Formerly VC-backed Bothell, WA 00 00000 000000&0 00000
0000000000000 Corporation New York, NY 000 000000 - 000
000000000 0000000 Formerly VC-backed Exton, PA 00 000.00 000000&0 000.00
00000000 00000000 Formerly PE-Backed Burlington, MA 000 000.00 00000000 000.00
You’re viewing 5 of 14 competitors. Get the full list »

TriReme Medical Executive Team (9)

Name Title Board Seat Contact Info
Randal Farwell Chief Financial Officer
Maria Pizarro Executive Vice President and Vice President, Research & Development
John Molyneux Vice President, Manufacturing
Shiva Ardakani Vice President of Regulatory Affairs and Quality Assurance
Eitan Konstantino Ph.D Co-Founder, President, Chief Executive Officer & Board Member
You’re viewing 5 of 9 executive team members. Get the full list »

TriReme Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TriReme Medical Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adams Street Partners Fund of Funds Minority 000 0000 000000 0
Bio*One Capital Corporate Venture Capital Minority 000 0000 000000 0
Luminor Capital Venture Capital Minority 000 0000 000000 0
Three Arch Partners Venture Capital Minority 000 0000 000000 0
Yellowstone Capital Partners PE/Buyout Minority 000 0000 000000 0
To view TriReme Medical’s complete investors history, request access »